Work

1128P Preliminary results of first-in-human study of 225-Actinium MTI-201 (225Ac-MTI-201) in metastatic uveal melanoma

Year: 2024

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.08.1196

Authors: N.I. Khushalani, G. El-Haddad, K. Gage, M. Budzevich, M. Schell, E.G. Moros, C. Tichacek, W. Gibbons, R. Rogers, M. Nickels, L. Tetteh, Z. Eroglu, L. Karapetyan, A.S. Brohl, J. Markowitz, A. Tarhini, K. Hayes, L. Hazlehurst, M. McLaughlin, D. Morse

Institutions: Moffitt Cancer Center, Washington University in St. Louis, Modulation Therapeutics (United States)

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4402560972

FWCI: 0.461

Cites:

Cited by: 2

Related to: 10